229 related articles for article (PubMed ID: 34492262)
21. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
[TBL] [Abstract][Full Text] [Related]
22. Ellagic Acid Enhances Apoptotic Sensitivity of Breast Cancer Cells to γ-Radiation.
Ahire V; Kumar A; Mishra KP; Kulkarni G
Nutr Cancer; 2017; 69(6):904-910. PubMed ID: 28718725
[TBL] [Abstract][Full Text] [Related]
23. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
Naruphontjirakul P; Viravaidya-Pasuwat K
Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
[No Abstract] [Full Text] [Related]
24. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
[TBL] [Abstract][Full Text] [Related]
25. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
26. Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells.
Wang N; Wang Q; Tang H; Zhang F; Zheng Y; Wang S; Zhang J; Wang Z; Xie X
J Exp Clin Cancer Res; 2017 Dec; 36(1):172. PubMed ID: 29197410
[TBL] [Abstract][Full Text] [Related]
27. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
28. Nanofabrication of methylglyoxal with chitosan biopolymer: a potential tool for enhancement of its anticancer effect.
Pal A; Talukdar D; Roy A; Ray S; Mallick A; Mandal C; Ray M
Int J Nanomedicine; 2015; 10():3499-518. PubMed ID: 25999714
[TBL] [Abstract][Full Text] [Related]
29. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
Khan MA; Zafaryab M; Mehdi SH; Quadri J; Rizvi MM
Int J Biol Macromol; 2017 Apr; 97():115-122. PubMed ID: 28082219
[TBL] [Abstract][Full Text] [Related]
30. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.
Trapani A; Denora N; Iacobellis G; Sitterberg J; Bakowsky U; Kissel T
AAPS PharmSciTech; 2011 Dec; 12(4):1302-11. PubMed ID: 21948322
[TBL] [Abstract][Full Text] [Related]
32. Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.
Habibullah MM; Mohan S; Syed NK; Makeen HA; Jamal QMS; Alothaid H; Bantun F; Alhazmi A; Hakamy A; Kaabi YA; Samlan G; Lohani M; Thangavel N; Al-Kasim MA
Drug Des Devel Ther; 2022; 16():1963-1974. PubMed ID: 35783198
[TBL] [Abstract][Full Text] [Related]
33. Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice.
Yadav M; Parle M; Sharma N; Dhingra S; Raina N; Jindal DK
Drug Deliv; 2017 Nov; 24(1):1429-1440. PubMed ID: 28942680
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Antitumor Efficacy of Chitosan-Tamarind Gum Polysaccharide Polyelectrolyte Complex Stabilized Nanoparticles of Simvastatin.
Malviya R; Raj S; Fuloria S; Subramaniyan V; Sathasivam K; Kumari U; Unnikrishnan Meenakshi D; Porwal O; Hari Kumar D; Singh A; Chakravarthi S; Kumar Fuloria N
Int J Nanomedicine; 2021; 16():2533-2553. PubMed ID: 33824590
[TBL] [Abstract][Full Text] [Related]
36. In vitro cytotoxicity and transfection efficiency of pDNA encoded p53 gene-loaded chitosan-sodium deoxycholate nanoparticles.
Hashem FM; Nasr M; Khairy A; Alqurshi A
Int J Nanomedicine; 2019; 14():4123-4131. PubMed ID: 31239671
[No Abstract] [Full Text] [Related]
37. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial.
Kim S; Gaber MW; Zawaski JA; Zhang F; Richardson M; Zhang XA; Yang Y
Biomaterials; 2009 Sep; 30(27):4743-51. PubMed ID: 19501395
[TBL] [Abstract][Full Text] [Related]
38. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
39. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
40. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]